345 related articles for article (PubMed ID: 23789951)
21. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
[TBL] [Abstract][Full Text] [Related]
22. Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level.
Al Rihani SB; Darakjian LI; Deodhar M; Dow P; Turgeon J; Michaud V
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916769
[TBL] [Abstract][Full Text] [Related]
23. In Vitro and Ex Vivo Model Systems to Measure ABC Transporter Activity at the Blood-Brain Barrier.
de Wit NM; Kooij G; de Vries HE
Curr Pharm Des; 2016; 22(38):5768-5773. PubMed ID: 27514708
[TBL] [Abstract][Full Text] [Related]
24. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.
Warren MS; Zerangue N; Woodford K; Roberts LM; Tate EH; Feng B; Li C; Feuerstein TJ; Gibbs J; Smith B; de Morais SM; Dower WJ; Koller KJ
Pharmacol Res; 2009 Jun; 59(6):404-13. PubMed ID: 19429473
[TBL] [Abstract][Full Text] [Related]
25. Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery.
Mohi-Ud-Din R; Mir RH; Mir PA; Banday N; Shah AJ; Sawhney G; Bhat MM; Batiha GE; Pottoo FH
Curr Drug Metab; 2022; 23(9):735-756. PubMed ID: 35980054
[TBL] [Abstract][Full Text] [Related]
26. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation.
Lemmen J; Tozakidis IE; Bele P; Galla HJ
Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159
[TBL] [Abstract][Full Text] [Related]
27. Expression and splicing of ABC and SLC transporters in the human blood-brain barrier measured with RNAseq.
Suhy AM; Webb A; Papp AC; Geier EG; Sadee W
Eur J Pharm Sci; 2017 May; 103():47-51. PubMed ID: 28188910
[TBL] [Abstract][Full Text] [Related]
28. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.
Miller DS
Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266
[TBL] [Abstract][Full Text] [Related]
29. Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach.
Potschka H
Pharmacol Ther; 2010 Jan; 125(1):118-27. PubMed ID: 19896502
[TBL] [Abstract][Full Text] [Related]
30. Topotecan central nervous system penetration is altered by a tyrosine kinase inhibitor.
Zhuang Y; Fraga CH; Hubbard KE; Hagedorn N; Panetta JC; Waters CM; Stewart CF
Cancer Res; 2006 Dec; 66(23):11305-13. PubMed ID: 17145877
[TBL] [Abstract][Full Text] [Related]
31. ABC transporters at the blood-brain barrier.
Mahringer A; Fricker G
Expert Opin Drug Metab Toxicol; 2016 May; 12(5):499-508. PubMed ID: 26998936
[TBL] [Abstract][Full Text] [Related]
32. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.
Dauchy S; Dutheil F; Weaver RJ; Chassoux F; Daumas-Duport C; Couraud PO; Scherrmann JM; De Waziers I; Declèves X
J Neurochem; 2008 Dec; 107(6):1518-28. PubMed ID: 19094056
[TBL] [Abstract][Full Text] [Related]
33. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
34. Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies.
Puech C; Hodin S; Forest V; He Z; Mismetti P; Delavenne X; Perek N
Int J Pharm; 2018 Nov; 551(1-2):281-289. PubMed ID: 30240829
[TBL] [Abstract][Full Text] [Related]
35. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
Shawahna R; Decleves X; Scherrmann JM
Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
[TBL] [Abstract][Full Text] [Related]
36. Drug efflux transporters in the CNS.
Sun H; Dai H; Shaik N; Elmquist WF
Adv Drug Deliv Rev; 2003 Jan; 55(1):83-105. PubMed ID: 12535575
[TBL] [Abstract][Full Text] [Related]
37. ABC transporters in the CNS - an inventory.
Hartz AM; Bauer B
Curr Pharm Biotechnol; 2011 Apr; 12(4):656-73. PubMed ID: 21118088
[TBL] [Abstract][Full Text] [Related]
38. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
Ohtsuki S; Terasaki T
Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
[TBL] [Abstract][Full Text] [Related]
39. Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.
Qosa H; Miller DS; Pasinelli P; Trotti D
Brain Res; 2015 Dec; 1628(Pt B):298-316. PubMed ID: 26187753
[TBL] [Abstract][Full Text] [Related]
40. ABC Transporters Are Key Players in Alzheimer's Disease.
Pereira CD; Martins F; Wiltfang J; da Cruz E Silva OAB; Rebelo S
J Alzheimers Dis; 2018; 61(2):463-485. PubMed ID: 29171999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
